KPV news and clinical trials
Also known as: Lys-Pro-Val · Alpha-MSH (11-13) · MSH 11-13 · KPV acetate · KPV free base
Updated 32 sources
7 new studies and 1 regulatory action in the last 12 months, newest first: trial registrations and results, PubMed papers, FDA actions and press coverage that name KPV. Each line links to the primary source.
October 2026
- StudyPubMedLysine-Proline-Valine attenuates oxidized low-density lipoprotein-induced foam cell formation and inflammatory responses in RAW264.7 macrophages (opens PubMed)
Researchers published a study on the tripeptide Lysine-Proline-Valine in macrophage models. Treatment with the peptide attenuated lipid accumulation and foam cell formation by suppressing reactive oxygen species and inflammatory signaling pathways.
Tissue & cellPMID 42854645
August 2026
- StudyPubMedKPV attenuates adipogenesis and lipid metabolism through modulation of ROS-mediated AKT/mTORC1/PPARγ signaling (opens PubMed)
Researchers published a study on the peptide KPV in preadipocytes and obese mice. Treatment with 100 μg/mL KPV suppressed adipocyte differentiation and reduced triglyceride content by approximately 38% in vitro, while oral administration alleviated diet-induced obesity in mice.
Tissue & cellPMID 42585803
May 2026
- StudyPubMedLysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells (opens PubMed)
Researchers published a study on the peptide KPV in hepatic HepG2 cells. Treatment with 100 µg/mL KPV significantly reduced lipid accumulation and fatty acid synthase expression induced by oleic acid by regulating the PPARγ pathway.
CytotechnologyPMID 42064835
April 2026
- RegulatoryFederal RegisterPharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List (opens Federal Register)
The FDA announced a public advisory committee meeting of the Pharmacy Compounding Advisory Committee to seek input on bulk drug substances nominated for the Section 503A bulk drug substances list.
NoticeFood and Drug Administration2026-07361
March 2026
- StudyPubMedA new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review (opens PubMed)
A critical review of peptide use in sports concludes that while peptides are marketed as safer alternatives to steroids for bodybuilding, long-term safety data is lacking and the unregulated supply chain poses significant health risks. Evidence for performance enhancement is limited.
The Journal of sports medicine and physical fitnessReviewPMID 41880199
January 2026
- StudyPubMedInflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers (opens PubMed)
Researchers published a study in Science Advances demonstrating a self-immolative peptide prodrug conjugate platform for oral delivery. In colitis mice, the KPV-based conjugate showed 3.8-fold greater colonic accumulation than free KPV, offering enhanced efficacy at a 20-fold lower dose.
Science advancesPMID 41533788
November 2025
- StudyPubMedHost defense peptides as a new drug lead to a strategy for inflammatory bowel disease (opens PubMed)
A review published in Drug Discovery Today examines host defense peptides as potential therapeutic candidates for inflammatory bowel diseases. The authors found that these peptides can modulate cytokine release and downregulate the NF-κB pathway to help restore homeostasis.
Drug discovery todayReviewPMID 41241376 - StudyPubMedExploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review (opens PubMed)
A review in the International Journal of Medical Sciences examines the use of tripeptides in wound healing and skin regeneration. The study highlights that tripeptides promote tissue repair by regulating cell migration, collagen deposition, and angiogenesis.
International journal of medical sciencesReviewPMID 41209547
Searched as: KPV, Lys-Pro-Val. Summaries are one or two sentences, published only when every number in them appears in the source record. A tracker, not medical advice.